Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biotechnology Index NYSE ETF
(NY:
FBT
)
170.23
-0.17 (-0.10%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biotechnology Index NYSE ETF
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
April 13, 2023
U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of...
Via
Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
April 13, 2023
A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug.
Via
Benzinga
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
April 12, 2023
New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this...
Via
Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
April 11, 2023
In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating...
Via
Benzinga
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
April 06, 2023
Via
Benzinga
US Judge Weighs Nationwide Ban On Abortion Pills
March 16, 2023
U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regulatory approval of the abortion pill mifepristone was proper. The judge is...
Via
Benzinga
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
March 01, 2023
Via
Benzinga
Lots Of & Increasing Evidence That Stocks Are Bottoming For Now
May 23, 2022
On Friday we saw one of the more violent trading days. Stocks jumped at the open, sold off sharply to new lows, and then rocketed back in the last hour to close basically unchanged.
Via
Talk Markets
How do Biotechnology Funds and ETFs Perform Over Five Years?
March 21, 2022
Biotech investing can be difficult for short-term traders but can offer good returns over five years if balanced with other healthcare positions like the XLV.
Via
Talk Markets
Biotech ETFs That Outperformed Last Week
December 20, 2021
Though the broad U.S. market saw a tumultuous ride last week with most of the sectors in red, biotechnology was the biggest gainer.
Via
Talk Markets
Biotech ETFs To Benefit From Latest Booster Update
August 21, 2021
Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from...
Via
Talk Markets
Exposures
COVID-19
Q2 Growth 'Nothing Short Of Virtuous': Economist
July 29, 2021
The coronavirus pandemic that began in 2020 and is persisting today has led many investors to hold poor market expectations. But maybe they shouldn’t be so pessimistic. What...
Via
Benzinga
Exposures
COVID-19
Top-Performing Biotech ETFs of Last Week
June 14, 2021
Investors may want to tap the bullishness in the biotech sector with the best biotech ETFs of last week.
Via
Talk Markets
5 Top ETFs With Exposure To Biogen
June 07, 2021
Here is a look at five ETFs with large exposure to Biogen shares.
Via
Talk Markets
5 Top ETFs With Exposure To Biogen
June 07, 2021
For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that...
Via
Benzinga
Exposures
Product Safety
Medical Miracles Inside Biotech ETFs
May 24, 2021
The events of the past year focused a lot of attention on game changing developments made possible by the global biotech industry. Of the major names Moderna is the one where the original research and...
Via
Talk Markets
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines
May 08, 2021
The Biden administration announced support for the waiver of intellectual property protections for COVID-19 vaccines proposed by South Africa and India. Let’s take a look at ETFs that can suffer from...
Via
Talk Markets
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.